T-cell Lymphomas
📧 Sign up to get email alerts when something new happens for T-cell Lymphomas.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas [Phase 1]
Phase 1 trial evaluating duvelisib in combination with romidepsin or with bortezomib for relapsed/refractory T-cell lymphomas has completed.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study of Ruxolitinib and Duvelisib in People With Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating the combination of ruxolitinib and duvelisib in patients with T-cell and NK-cell lymphomas is currently …
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas [Phase 2]
Phase 2 trial evaluating low-dose chidamide as maintenance therapy after allogeneic hematopoietic stem cell transplantation in T-cell acute …
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma [Phase 2]
A Phase 2 trial evaluating infusion of blood cells (lymphocytes) to stimulate the immune system for fighting leukemia/lymphoma was terminate…